Postmarketing Safety Surveillance.
- Published in:
- Drug Safety, 2013, v. 36, n. 3, p. 183, doi. 10.1007/s40264-013-0018-x
- By:
- Publication type:
- Article
Works matching IS 01145916 AND DT 2013 AND VI 36 AND IP 3
Results: 10
1
2
Intentional rechallenge and the clinical management of drug-related problems.
- Published in:
- 2013
- By:
- Publication type:
- journal article
3
Dealing with global safety issues : was the response to QT-liability of non-cardiac drugs well coordinated?
- Published in:
- 2013
- By:
- Publication type:
- journal article
4
Distinguishing Hazards and Harms, Adverse Drug Effects and Adverse Drug Reactions.
- Published in:
- Drug Safety, 2013, v. 36, n. 3, p. 147, doi. 10.1007/s40264-013-0019-9
- By:
- Publication type:
- Article
5
Postmarketing safety surveillance : where does signal detection using electronic healthcare records fit into the big picture?
- Published in:
- 2013
- By:
- Publication type:
- journal article
6
How Do Patients Contribute to Signal Detection?
- Published in:
- Drug Safety, 2013, v. 36, n. 3, p. 199, doi. 10.1007/s40264-013-0021-2
- By:
- Publication type:
- Article
7
Dealing with Global Safety Issues.
- Published in:
- Drug Safety, 2013, v. 36, n. 3, p. 167, doi. 10.1007/s40264-013-0016-z
- By:
- Publication type:
- Article
8
How do patients contribute to signal detection? : A retrospective analysis of spontaneous reporting of adverse drug reactions in the UK's Yellow Card Scheme.
- Published in:
- 2013
- By:
- Publication type:
- journal article
9
Intentional Rechallenge: Does the Benefit Outweigh the Risk?
- Published in:
- Drug Safety, 2013, v. 36, n. 3, p. 155, doi. 10.1007/s40264-013-0020-3
- By:
- Publication type:
- Article
10
Intentional Rechallenge and the Clinical Management of Drug-Related Problems.
- Published in:
- Drug Safety, 2013, v. 36, n. 3, p. 163, doi. 10.1007/s40264-013-0023-0
- By:
- Publication type:
- Article